What is the difference between a clinical trial and a case report?
A randomized clinical trial compares groups that were assigned by chance, which helps show whether a treatment caused a difference. A case report describes one patient, or a few, with no comparison group. Case reports can raise questions and flag safety problems, but they cannot show cause and effect or how common a result is. Neither one tells you what will happen to you.
Sources checked against Europe PMC abstracts and FDA/DailyMed label text: Nov 17, 2026; full text not read for abstract-only claims (recheck on publication date)
Quick answer
A randomized clinical trial compares groups that were assigned by chance, which helps show whether a treatment caused a difference. A case report describes one patient, or a few, with no comparison group. Case reports can raise questions and flag safety problems, but they cannot show cause and effect or how common a result is. Neither one tells you what will happen to you.
Two kinds of evidence
- Randomized trial: participants are assigned by chance to a treatment or a comparison group. Randomization is the only method that controls for known and unknown factors that could differ between groups.
- Case report or case series: a description of one patient or a few. Merits listed in the review: detecting novelties, generating hypotheses and pharmacovigilance. Limits: no ability to generalize, no way to establish cause and effect, risk of over-interpretation and publication bias.
Randomized controlled trials sit at the top of the usual hierarchy of evidence, controlled observational studies in the middle, and uncontrolled studies and opinion at the bottom. Randomization is the only method that controls for known and unknown factors that could affect the groups. The authors of that review note that the hierarchy has been challenged: two reports found nonsignificant differences between the results of randomized trials and observational studies. Source: Hierarchy of evidence: from case reports to randomized controlled trials.
Source for case reports: The clinical case report: a review of its merits and limitations.
Examples from this library

Study design and size
- A randomized trial: STEP 1 randomized 1,961 adults to semaglutide 2.4 mg or placebo for 68 weeks. SELECT enrolled 17,604 adults. Sources: STEP 1; SELECT.
- An observational study without a control group: a retrospective study of 277 patients at one Swiss obesity clinic described real-world liraglutide use. It cannot show what would have happened without the drug. Source: Swiss obesity clinic study, 2021.
- Very small uncontrolled studies: a 2026 systematic review of human BPC-157 research found three studies with 30 people in total, judged poor quality with very low certainty of evidence. Source: systematic review.
Questions to ask when you read a result
- Was there a comparison group, and how were people assigned?
- How many people were studied, for how long, and who were they?
- What was measured, and was it an outcome that matters to you or a lab marker?
- Does the claim go further than what was measured?
What this does not establish
A bigger or randomized study is not always better for every question, and a small study is not necessarily wrong. This page does not judge any particular treatment. Trial averages describe groups, not you.
FAQs
What is the difference between a clinical trial and a case report? A trial compares groups, often with random assignment. A case report describes one or a few patients and cannot show cause and effect.
Can a case report be useful? Yes, for raising questions and flagging possible safety signals, but not for showing a treatment works.
What should I ask my clinician about a study I read? Whether it applies to your situation and what stronger evidence exists.
Sources
- Hierarchy of evidence: from case reports to randomized controlled trials
- The clinical case report: a review of its merits and limitations
- Wilding et al., STEP 1, N Engl J Med 2021
- Lincoff et al., SELECT, N Engl J Med 2023
- Swiss obesity clinic liraglutide study, 2021
- Human evidence for BPC-157, systematic review, 2026